Your Location：
Home >
Browse articles >
Gene therapy with antisense c-myc adenovirus for human gastric carcino-ma cell line in vitro and for implanted carcinoma in nude mice
Updated：2026-03-12
Previous|Next

    • Gene therapy with antisense c-myc adenovirus for human gastric carcino-ma cell line in vitro and for implanted carcinoma in nude mice

    • Military Medical Research Vol. 0, Issue 2, Pages: 111-114(2000)

    Scan QR Code

  •  
  •  

  • Full Text(HTML)

  • Publication Info

  • Metrics

Sections
icon
The trial reading is over, you can activate your VIP account to continue reading.
Deactivate >
icon
The trial reading is over. You can log in to your account, go to the personal center, purchase VIP membership, and read the full text.
Already a VIP member?
Log in >

6

Views

4

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Recent advances in CRISPR-based genome editing technology and its applications in cardiovascular research
Ionizable drug delivery systems for efficient and selective gene therapy
Novel gene therapy for rheumatoid arthritis with single local injection: adeno-associated virus-mediated delivery of A20/TNFAIP3
Melatonin inhibits ESCC tumor growth by mitigating the HDAC7/β-catenin/c-Myc positive feedback loop and suppressing the USP10-maintained HDAC7 protein stability
Frostbite: diagnosis, treatment, prognosis, and future directions

Related Author

Xiao Yang
Jian Wang
Jing-Ping Xu
Jun Wang
Zhen-Hua Li
Ran-Ran Guo
Yu-Qi Zhang
Yong-Hu Chen

Related Institution

Yaneng BIOScience (Shenzhen) Co., Ltd.
State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences, Beijing Institute of Lifeomics
School of Pharmacy, Yanbian University
Faculty of Medical Device, Shenyang Pharmaceutical University
Wuya College of Innovation, Shenyang Pharmaceutical University